Five-year biochemical recurrence-free and overall survival following high-dose-rate brachytherapy with additional external beam or radical prostatectomy in patients with clinically localized prostate cancer
详细信息 查看全文
- 作者：Katharina Boehm ; MDa ; b ; f ; kboehm@uke.de" class="auth_mail" title="E-mail the corresponding author ; Jonas Schiffmann ; MDh ; Zhe Tianc ; Hans Lesmana ; MDd ; Alessandro Larcher ; MDb ; e ; Philipp Mandel ; MDa ; f ; Pierre I. Karakiewicz ; MDb ; g ; Markus Graefena ; Rudolf Schwarz ; MDd ; Andreas Krü ; ll ; MDd ; Derya Tilkia ; f
- 关键词：Prostate cancer ; Brachytherapy ; High dose rate ; Biochemical recurrence ; Radical prostatectomy
- 刊名：Urologic Oncology: Seminars and Original Investigations
- 出版年：2016
- 出版时间：March 2016
- 年：2016
- 卷：34
- 期：3
- 页码：119.e11-119.e18
- 全文大小：394 K
文摘
- •
High-dose-rate brachytherapy and external-beam radiation therapy offer equivalent oncological control to that from radical prostatectomy.
- •
This is exclusively true for patients who receive additional androgen deprivation therapy.
- •
Patients who receive radical prostatectomy generally avoid androgen deprivation therapy (2%) and its morbidity.